<!DOCTYPE html><html lang="zh-CN"><head><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta charset="utf-8"><meta property="qc:admins" content="10210420621156375"><meta name="renderer" content="webkit"><title>我是_一级棒: 新型减肥药beloranib临床试验结果喜人 美国Zafgen公司公布了一项作用机制不同于... - 雪球</title><script>var _write = document.write;
var write = function (str) {
  SNB = window.SNB || {};
  if (_write.apply) {
    SNB.docWrite = function (str) {
      _write.apply(document, arguments);
    }
  } else {
    SNB.docWrite = _write;
  }
};

document.write = write;
</script><meta name="keywords" content="我是_一级棒: 新型减肥药beloranib临床试验结果喜人 美国Zafgen公司公布了一项作用机制不同于... - 雪球"><meta name="description" content="我是_一级棒: 新型减肥药beloranib临床试验结果喜人 美国Zafgen公司公布了一项作用机制不同于... - 雪球"><!--<link rel="shortcut icon" href="http://xueqiu.com/favicon.ico">--><link rel="icon" type="image/png" href="http://assets.xueqiu.com/images/favicon.png"><style>html {display:none}</style><script>if (self == top) {
  document.documentElement.style.display = 'block';
} else if (top.location.host !== 'xueqiu.com') {
  top.location = self.location;
}
var WATCH = {};
WATCH.appStart = 1412447590742
WATCH.pageStart = (new Date()).getTime()</script><link rel="stylesheet" href="http://assets.xueqiu.com/style/bootstrap-6d8d95.css"><style>body{
  padding-top:40px;
}
/* TODO */
.search .dropdown-menu strong{
  height:12px;
  line-height:12px;
}</style><link rel="apple-touch-icon-precomposed" href="http://assets.xueqiu.com/images/icon-144.png"><script src="http://assets.xueqiu.com/js/xdomain.js" slave="https://xueqiu.com/proxy.html"></script><script src="http://assets.xueqiu.com/js/SNB.lib.bundle-5c5fa0.js"></script></head><body id="jade-single" class="left  isPC isNotMobile isNotPad"><script>SNB = window.SNB || {};
jQuery.extend(SNB, {
  data: {},
  env: "production",
  Views: {},
  Templates: {},
  Models: {},
  Collections: {},
  domain: {"host":"http://xueqiu.com","base":"http://api.xueqiu.com","photo":"http://photo.xueqiu.com","stock":"http://api.xueqiu.com","static":"http://assets.xueqiu.com","staticHttps":"https://js.xueqiu.com","upyun":"http://xqimg.b0.upaiyun.com","pdf":"http://doc.xueqiu.com","im":"http://api.xueqiu.com","shared":"/data/source/snowball-fe/shared/","file":"http://xqfile.imedao.com/"},
  currentUser: {"isGuest":true},
  jsVersion: {"05.jquery.cookie.js":"11886a","08.templates.js":"5133fe","SNB.TopicList.js":"1f9344","SNB.UsersList.js":"f40cd0","SNB.atDialog.js":"5f446d","SNB.base.js":"51baf8","SNB.base_simple.js":"a58306","SNB.bind_verify.js":"05e9a6","SNB.calendar.js":"dbd6b4","SNB.calendarDialog.js":"8e1f43","SNB.calendarSubscribe.js":"10a87a","SNB.capitalReturnRateChart.js":"e27d9c","SNB.cardDialog.js":"d47fc0","SNB.commentView.js":"d64dc3","SNB.commonFriends.js":"59ee01","SNB.companyInfo.js":"257ce9","SNB.dialog.js":"2cb35b","SNB.dm.js":"feba6b","SNB.dmDialog.js":"f9756a","SNB.downloadDialog.js":"039a4a","SNB.editor.emotion.js":"66dc3f","SNB.editor.js":"aefa46","SNB.eventShare.js":"13011a","SNB.financeTableDataInfo.js":"02255c","SNB.follower.js":"41b8c8","SNB.friends.js":"20db8d","SNB.g.bar.js":"8a1a31","SNB.guest.js":"62785b","SNB.guide.js":"0f7d4a","SNB.helpers.js":"2caa71","SNB.his_home.js":"d7e739","SNB.holdStockChart.js":"3a1ecf","SNB.home.js":"278b62","SNB.hotStock.js":"3fbde9","SNB.im.contacts.js":"f14070","SNB.im.dialog.js":"891a76","SNB.im.emotions.js":"66c72d","SNB.im.group_applys.js":"c96b4e","SNB.im.group_joined.js":"3f2691","SNB.im.js":"53fb31","SNB.im.message.js":"fc4adf","SNB.im.model.js":"5b543b","SNB.im.net.js":"351bbe","SNB.im.peer_chat.js":"af7c74","SNB.im.session_item.js":"16c0cf","SNB.im.sessions_list.js":"42664f","SNB.im.setting.js":"a1815b","SNB.im.stranger.js":"5a5a9d","SNB.im.utils.js":"9bd33d","SNB.imeigu_fund_topic.js":"b19eb9","SNB.imeigu_index.js":"040f69","SNB.index.login.js":"1e931b","SNB.inner_trade.js":"545aff","SNB.interest.js":"9191eb","SNB.interview.js":"c98e5d","SNB.kline.js":"b7be75","SNB.lib.bundle.js":"5c5fa0","SNB.lib.mobile.js":"3dd1be","SNB.modify_email.js":"5e659d","SNB.newChart.js":"cb67ba","SNB.newChart.mobile.js":"9f6ea8","SNB.newProfile.js":"64062c","SNB.password.js":"292e24","SNB.pdfDialog.js":"549e36","SNB.performance-year.js":"cc6402","SNB.performance.js":"73a4ef","SNB.performanceChart.js":"7fdc96","SNB.performanceView.js":"f8df12","SNB.performance_mobile.js":"69c3ba","SNB.personality.js":"fa2de9","SNB.portfolio.js":"5baf5f","SNB.portfolioNew.js":"08084c","SNB.portfolioShareDialog.js":"cbb457","SNB.profile_info.js":"909f86","SNB.recommend.js":"133267","SNB.renderTableTrHtml.js":"893240","SNB.renderUserView.js":"f1b747","SNB.reportSpam.js":"1c8674","SNB.repostDialog.js":"0505d2","SNB.sameFriend.js":"d9ef9a","SNB.search.js":"931048","SNB.search_ipad.js":"c46a2a","SNB.search_stock_ipad.js":"67fab6","SNB.setting_user.js":"3689c3","SNB.shareDialog.js":"c0880d","SNB.similarUsers.js":"aaf45d","SNB.singleStock.js":"613aa1","SNB.status-edit.js":"516e4c","SNB.status.js":"55c610","SNB.status_mobile.js":"a2eb0d","SNB.stockActiveUser.js":"00890d","SNB.stockFollowers.js":"d5d20f","SNB.stockList.js":"7f3778","SNB.stockList_new.js":"27f2d7","SNB.stockNews.js":"683e54","SNB.stockRecommend.js":"531832","SNB.stockScreener.js":"8c0816","SNB.stockStatus.js":"eae6ba","SNB.talks.js":"06fa1b","SNB.third_oauth.js":"7f7d9b","SNB.tipsTalk.js":"b57584","SNB.tipsTopic.js":"627030","SNB.today.js":"c63624","SNB.today.lib.js":"0ccb49","SNB.today_topic.js":"a44f40","SNB.tooltip.js":"411b72","SNB.topInfluence.js":"a76b38","SNB.trans.js":"8dbbe6","SNB.tweetDialog.js":"7b11aa","SNB.typeahead.js":"435845","SNB.userRecommend.js":"c37291","SNB.userRemark.js":"a8a7b8","SNB.validator.js":"499684","SNB.weiboUser.js":"411888","ajaxfileupload.js":"3eb75d","backbone.0.9.10.js":"2514c4","bootstrap.js":"946d7c","calendar.js":"e52c7d","checkLogin.js":"ba70b7","common/SNB.helpers.js":"34b605","common/backbone_1.1.2.js":"918bfb","common/css3-mediaqueries.js":"0328e2","common/jquery-1.9.1.js":"6eb28e","common/json.js":"61f18d","common/lib/jquery-1.9.1.js":"6eb28e","common/lib/sea-2.3.0.js":"4124f1","common/lib/sea.extend.js":"615299","common/lib/xdomain.js":"ec12c0","common/lib.js":"b1d356","common/sea-2.3.0.js":"4124f1","common/sea.js":"04b0ad","common/underscore_1.6.0.js":"65e9a8","common/util/image.js":"9d3c5f","common/util/jade.runtime.js":"c53f1c","common/util/jquery.extend.js":"6f2c72","common/util/jquery.formSerialize.js":"e9ee18","common/util/observer.js":"d0a9cf","common/util/password.js":"ef54ef","common/util.js":"9eecb7","common/zepto-core-fx.1.1.3.js":"059c1b","config.js":"5401c0","fittext.js":"7c488c","flexpaper.js":"35419f","flexpaper_handlers.js":"e84404","fullcalendar.js":"b7529e","g.bar.js":"4aaee7","g.pie.js":"ddd48b","g.raphael.js":"6fa395","hammer.js":"0ff79c","highlight.js":"82892c","iScroll.js":"e3073f","im2014/base.adapter.deliver.js":"131bf1","im2014/base.adapter.js":"04ea29","im2014/base.config.js":"99fc69","im2014/base.js":"b9e6bf","im2014/base.net.js":"1e3b30","im2014/base.utils.js":"49e303","im2014/db.contacts.js":"c48901","im2014/db.groups.js":"9e8d32","im2014/db.js":"4c06de","im2014/db.message.helper.js":"f693a5","im2014/db.messages.js":"e9d207","im2014/db.sessions.js":"5ab748","im2014/im.js":"d6f0d9","im2014/session.dialog.js":"a49341","im2014/session.editor.js":"ff3a73","im2014/session.gmm.js":"80f55a","im2014/session.item.js":"2ce642","im2014/session.joingroup.js":"15b826","im2014/session.list.js":"33d72b","im2014/session.message.js":"f5ca74","im2014/session.setting.js":"92ca63","im2014/widget.emotion.js":"80509d","im2014/widget.joingroup.js":"809381","im2014/widget.requestjoingroup.js":"aab5b4","im2014/widget.search.js":"646924","im2014/widget.uploader.js":"020117","im2014/widget.viewer.js":"57568f","im_group_apply.js":"28371d","imeigu_portfolioIframe.js":"a15a8e","imgPlugin.js":"f476c7","imgUpload.js":"8e34c5","infinity.min.js":"83d6da","jquery.galleriffic.js":"604a31","jquery.hammer.js":"eef779","jquery.history.js":"9f2888","jquery.imgareaselect.js":"8c0be1","jquery.lazyload.min.js":"21789e","jquery.mousewheel.js":"d4c91c","jquery.plugin.pullToRefresh.js":"717b1d","jquery.rotate.1-1.js":"212e62","jquery.simplePagination.js":"eb8c40","jquery.tagsinput.js":"24a387","jquery.ui.js":"dff010","jquery.uploadify.js":"13188e","jquery.watermark.js":"5d50f1","lib/autoresize.js":"8cafb1","lib/store.js":"3024c3","lib/ueditor.js":"ae2d6f","lib/upload.js":"c9e869","login.js":"12bd5c","pages/event/jiashi.js":"56cb1e","pages/invest/SNB.chart_base.js":"804128","pages/invest/SNB.fund_chart.js":"ed22cb","pages/invest/SNB.mobile_chart.js":"3280eb","pages/invest/SNB.mobile_stock.js":"770aad","pages/invest/SNB.profile_broker_rank.js":"f80f78","pages/invest/SNB.rank.js":"ea7037","pages/pay/deposit-mobile.js":"3a98c6","pages/pay/deposit.js":"43cbfe","pages/pay/donate-mobile.js":"96562d","pages/pay/pin.js":"9804fc","pages/pay/withdraw.js":"6a9907","pages/single.js":"1b6212","pages/sns/single.js":"e8b9ba","pages/today/mobile.index.js":"52bbbe","perfect-scrollbar-0.4.8.with-mousewheel.min.js":"65d42c","sea.js":"f681ab","share-to-xueqiu.js":"68e861","single.js":"d0071c","slides.jquery.js":"47f4d2","step01.js":"a14412","userSearch.js":"b678a8","widget/TSNB.comment.js":"64ba15","widget/TSNB.donate.js":"4d75dc","widget/TSNB.typeahead.js":"c29ea7","widget/TSNB.user.js":"3b5d1a","widget/backbone1.1.2.js":"f54860","widget/bootstrap/affix.js":"144d54","widget/bootstrap/alert.js":"69f62b","widget/bootstrap/button.js":"889c5d","widget/bootstrap/carousel.js":"553d19","widget/bootstrap/collapse.js":"826c39","widget/bootstrap/dropdown.js":"b734b9","widget/bootstrap/modal.js":"06f804","widget/bootstrap/popover.js":"eec180","widget/bootstrap/scrollspy.js":"98fe40","widget/bootstrap/tab.js":"25b608","widget/bootstrap/tooltip.js":"be65c7","widget/bootstrap/transition.js":"bf59a8","widget/bootstrap/typeahead.js":"d7aba8","widget/bootstrap.js":"9eecb7","widget/donate.js":"55d2f8","widget/donate_tooltip.js":"904b16","widget/editor/at.js":"a14217","widget/editor/emotion.js":"c328ef","widget/editor.js":"06f435","widget/emotions.js":"f9e068","widget/favorite.js":"687c11","widget/flexpaper/flexpaper.js":"35419f","widget/flexpaper/flexpaper_handlers.js":"29cd08","widget/forward.js":"366ab0","widget/global_pin.js":"3a3b9c","widget/lodash.underscore.js":"624760","widget/mobile/action.js":"a2422c","widget/mobile/form.js":"e09067","widget/mobile/modal.js":"e3e037","widget/mobile/overlay.js":"46240c","widget/modal.js":"619958","widget/nav/typeahead.js":"fd1f25","widget/profile_pin.js":"4f3d6e","widget/report_spam.js":"80048f","widget/repost_comment.js":"30ca31","widget/share.js":"c0dc50","widget/tmp/SNB.base.js":"dc40b0","widget/tmp/json.js":"61f18d","widget/umeditor/lang/zh-cn/zh-cn.js":"84bd0f","widget/umeditor/umeditor.config.js":"3399f6","widget/umeditor/umeditor.js":"69f6e5","widget/underscore1.6.0.js":"65e9a8","widget/util/jquery.formSerialize.js":"6a0201","widget/util/notice.js":"113223","widget/util/password.js":"ef54ef","widget/util/share.js":"c0dc50","widget/util.js":"9eecb7","xdomain.js":"ec12c0","zepto.js":"3494da"},
  cssVersion: {"about.css":"3a795e","bootstrap-lite.css":"ecc11f","bootstrap.css":"6d8d95","bootstrap_full.css":"1bbfeb","chart.css":"d41d8c","common/base.css":"c6404f","common/css3/inline-block.css":"198680","common/grid.css":"a3bf41","common/layout.css":"72e9b8","common/mobile.css":"f623b0","common/mod.css":"913794","common/nav-bar.css":"33b4bb","common/pager.css":"d50aa1","common/reset.css":"fc925b","common/var.css":"4449f7","default_mobile.css":"809d82","dh.css":"b357d7","editor.css":"b8a9fa","editor_inline.css":"04d6dd","flexpaper.css":"337d49","form.css":"9c1799","fullcalendar.css":"f41d7e","guide_overlay.css":"4cc763","icon.css":"d6f7d8","im.css":"23895a","im2014.css":"946177","imgroup.css":"827b78","jinNang.css":"d77ba1","jinnang_1394597838763.css":"d77ba1","jquery.tagsinput.css":"894d3a","jquery.ui.css":"3901d0","mentions_block.css":"14f9d2","mocha.css":"c67a75","newChart.css":"68ea2e","pages/TSNB.about.css":"e2e89a","pages/event/jiashi.css":"e8f618","pages/home.css":"e27163","pages/imeigu.css":"fa944c","pages/invest/dealList.css":"7521b1","pages/invest/mobile_chart.css":"aca604","pages/invest/mobile_performance.css":"d1eace","pages/invest/mobile_stock.css":"7e3ebd","pages/invest/profile_broker_rank.css":"62eb59","pages/invest/rank.css":"e8c496","pages/invest/stock_chart.css":"440a70","pages/mobile/common.css":"e3b035","pages/mobile/vars.css":"d41d8c","pages/pay/wallet-mobile.css":"749c88","pages/pay/wallet.css":"3526e5","pages/pin/pin-mobile.css":"5291ab","pages/post.css":"736b7d","pages/profile.css":"d4e0ed","pages/sns/TSNB.single.css":"eab305","pages/status.css":"ed679d","pages/tip.css":"75faec","pages/today/index-mobile.css":"55ce0c","performance-year-mobile.css":"3c30b3","performance-year.css":"d4767e","personality-ie8.css":"be1bde","personality.css":"e95152","portfolioIframe.css":"8ab1a0","portfolioNew.css":"155c11","pull-to-refresh.css":"7a169b","searchBar.css":"2b5230","simplePagination.css":"ef4ec1","snowbrick.css":"194559","status_mobile.css":"2c30e0","status_operate_btn.css":"6ed0ad","today_topic.css":"9f2379","tooltip.css":"1d3327","touch/common.css":"9be414","touch/normal.css":"2eb72c","uploadify.css":"60f6c0","userRecommend.css":"a09164","widget/TSNB.comment.css":"b5a87a","widget/TSNB.donate.css":"41d58d","widget/TSNB.donate_tooltip.css":"1d0aa7","widget/TSNB.report_spam.css":"4ae2f0","widget/TSNB.share.css":"081f3a","widget/TSNB.status.css":"05e25b","widget/bootstrap/media.css":"864f9a","widget/bootstrap/mixins/background-variant.css":"d41d8c","widget/bootstrap/mixins/border-radius.css":"d41d8c","widget/bootstrap/mixins/center-block.css":"d41d8c","widget/bootstrap/mixins/clearfix.css":"d41d8c","widget/bootstrap/mixins/hide-text.css":"d41d8c","widget/bootstrap/mixins/labels.css":"d41d8c","widget/bootstrap/mixins/nav-divider.css":"d41d8c","widget/bootstrap/mixins/nav-vertical-align.css":"d41d8c","widget/bootstrap/mixins/opacity.css":"d41d8c","widget/bootstrap/mixins/progress-bar.css":"d41d8c","widget/bootstrap/mixins/reset-filter.css":"d41d8c","widget/bootstrap/mixins/resize.css":"d41d8c","widget/bootstrap/mixins/responsive-visibility.css":"d41d8c","widget/bootstrap/mixins/tab-focus.css":"d41d8c","widget/bootstrap/mixins/text-emphasis.css":"d41d8c","widget/bootstrap/mixins/text-overflow.css":"d41d8c","widget/bootstrap/normalize.css":"d4e0cf","widget/bootstrap/print.css":"de423d","widget/bootstrap/responsive-embed.css":"502656","widget/bootstrap/variables.css":"d41d8c","widget/donate.css":"4146e9","widget/donate_tooltip.css":"5b3334","widget/global_pin.css":"7e7634","widget/mobile/modal.css":"b66924","widget/mobile/normal.css":"2eb72c","widget/mobile/top-bar.css":"80f19f","widget/modal.css":"b84135","widget/profile_pin.css":"3900fc","widget/umeditor/editor.css":"b2dcf7","widget/umeditor/umeditor.css":"116f52","widget/util/page.css":"c48d21","widget.css":"b3b396","widget_user.css":"8c1360"},
  staticDomain: 'http://assets.xueqiu.com',
  bid : ''
});

SNB.data.access_token =  $.cookie("xq_a_token") || "DqFet1kwTwBPMvfzSNwbot";

if(SNB.bid !== '' && document.cookie.indexOf('bid='+SNB.bid) === -1){
  var search = window.location.search.split('&');
  search.push('_=' + (+new Date).toString(36));
  window.location.search = search.join('&');
}

    //-    if (SNB.currentUser.id && !$.cookie("xq_a_token")) {
    //-      $.ajax({
    //-        url: "/service/token",
    //-        async: false
    //-      })
    //-    }
    </script><script src="http://assets.xueqiu.com/js/05.jquery.cookie.js"></script><script>function delCookie(name){//为了删除指定名称的cookie，可以将其过期时间设定为一个过去的时间
  var date = new Date();
  date.setTime(date.getTime() - 10000);
  document.cookie = name + '=a; expires=' + date.toGMTString();
}
/*
if(!$.cookie('xq_refresh') && $.cookie('xq_a_token')){
  $.ajax({
    url: '/user/refreshCookie',
    async: false
  }).done(function(){
    delCookie('xq_a_token');
    delCookie('xq_r_token');
    delCookie('xq_token_expire');
  });
}
*/
jQuery(function($){
  $('.navbar a.exit').on('click', function(){
    try{
      delCookie('xq_a_token');
      delCookie('xq_r_token');
      delCookie('xq_token_expire');
    } catch(e){
      console.log(e);
    }
  });
});</script><script src="http://assets.xueqiu.com/js/SNB.helpers-2caa71.js"></script><script>SNB.profileUser = {"status":1,"common_count":0,"remark":null,"screen_name":"我是_一级棒","verified":false,"verified_type":0,"profile":"/smarttraders168","verified_description":null,"followers_count":2677,"status_count":631,"friends_count":34,"last_status_id":31969497,"donate_count":1,"blocking":false,"following":false,"follow_me":false,"recommend":null,"city":"城市/地区","gender":"m","province":"广东","st_color":"0","allow_all_stock":false,"step":"three","blog_description":null,"intro":null,"stock_status_count":null,"stocks_count":null,"domain":"smarttraders168","name":null,"location":null,"id":2489249469,"type":"1","url":null,"description":"小赌怡情，大赌致富。宇宙职业独立投资人。","group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/20149/1412354828279-1412354828652.jpg!50x50.png"}</script><noscript><style>html {
  display: block
}</style><p class="ie6">当前浏览器禁用了JavaScript，导致不能正常使用雪球的功能，请打开JavaScript后再访问本站。</p></noscript><!--[if lt IE 8]><div class="ie6">你正在使用的浏览器版本过低（IE7或IE7以下，包括套用了IE内核的360浏览器、搜狗浏览器等）。<br />如果不能正常浏览本站或某些功能无法使用，请到微软官网下载升级 <a href="http://windows.microsoft.com/zh-CN/internet-explorer/downloads/ie">Internet Explorer</a> 或使用 <a href="http://www.google.com/chrome/">谷歌 Google Chrome</a> 浏览器。</div><![endif]--><div class="temp"></div><div class="navbar navbar-fixed-top"><div class="navbar-inner"><div class="container"><h1 id="logo"><a href="/"><img title="返回我的首页" src="http://assets.xueqiu.com/images/logo@2x.png" width="54px" height="30px" alt="雪球"></a></h1><div class="search"><form method="get" action="/k"><input id="quick-search" name="q" type="text" autocomplete="off" placeholder="搜索 股票/讨论/用户/群组" class="typeahead"></form><span class="icon"><i></i></span></div><ul class="nav pull-right account notlogined"><li><a href="/account/reg" class="reg">注册</a></li><li><a href="/" class="login">登录</a></li></ul></div></div></div><!--!=css('im.css')--><script>seajs.config({
  timeout: 60000,
  preload: [SNB.jsVersion && _.keys(SNB.jsVersion).length ? 'SNB.base-' + SNB.jsVersion['SNB.base.js'] + '.js' : 'SNB.base.js']
})
</script><script>seajs.use("SNB.guest.js")
</script><script>;(function () {
  var keys = _.keys(SNB.jsVersion)
    , map = [];
    
  if (keys.length) {
    _.each(keys, function(k) {
      var reg = new RegExp('\\/(' + k.replace(/\./g, '\\.') + ')(\\?.*|$)');
      
      map.push([reg, function (all, fileName, param) {
        var result = '/' + fileName.replace(/\.js$/i, '') + '-' + SNB.jsVersion[k] + '.js';
        
        if (param) {
          result += param;
        }
        
        return result;
      }]);
    });
    
    seajs.config({
      map: map
    });
  }
}())
</script><!-- test config--><script src="http://assets.xueqiu.com/js/bootstrap-946d7c.js"></script><div id="center" class="container"><div class="left-sidebar"><div class="wrapper"><div class="widget"><div class="person-info head-list"><a href="/smarttraders168/profile" data-name="我是_一级棒" class="profile_info_pic"><img src="http://xavatar.imedao.com/community/20149/1412354828279-1412354828652.jpg!50x50.png" alt="我是_一级棒" width="50px" height="50px" class="shadow"/></a></div></div></div></div><div class="main"><div style="display:none" class="loading"></div><div class="wrapper"><link rel="stylesheet" href="http://assets.xueqiu.com/style/pages/post-736b7d.css"><div id="status_31169985" class="status single-status content head-list"><div class="detail"><a href="/smarttraders168" data-name="我是_一级棒">我是_一级棒<span data-name="我是_一级棒" style="display:none" class="user_remark">()</span></a>:<h3>新型减肥药beloranib临床试验结果喜人</h3><div class="statusContent">美国Zafgen公司公布了一项作用机制不同于以往的新型减肥药的临床试验结果，结果显示该药能使肥胖患者减重24磅或减轻原先体重的11%。<br><br>　　这种名为beloranib的注射剂型减肥新药由Zafgen公司生产，该药在降低血HDL-C及血压水平方面的有效性和安全性在二期临床试验中得到了充分肯定。<br><br>　　纵观减肥市场，各种减肥药物层出不穷，已有相当一部分减肥药物因存在安全隐患而被撤市。减肥药安全性方面的担忧主要与其作用机制有关——大多数减肥药通过向大脑传递饱食感的信号而抑制食欲。<br><br>　　美国FDA于2012年年中批准了减肥药Qsymia(一种苯丁胺和托吡酯的混合缓释制剂)和Belviq(氯卡色林)的上市，上述两种药物的作用机制主要与大脑信号转导有关，具体通路尚不清楚。然而均存在一定程度的副作用，包括引起抑郁焦虑情绪、心脏损害，甚至可致畸。<br><br>　　beloranib的作用机制与传统减肥药有所不同，它主要通过抑制脂酸产生和利用过程中的关键酶甲硫氨酰氨肽酶-2(MetAP2)的活性，从而使机体脂质的产生减少，代谢增加。<br><br>　　147名肥胖患者参与了此次临床试验，结果显示，在经过12周的治疗后，beloranib组(用药达最大剂量)与安慰剂组的受试者分别减重24磅和0.9磅。<br><br>　　Qsymia的两组独立后期试验(平均疗程为56周)结果显示患者分别减重30磅和37磅，Belviq的一项临床试验(疗程为52周)结果显示患者平均减重17磅。<br><br>　　Beloranib最常见的副作用包括恶心，腹泻，头痛，注射局部淤血及失眠。<br><br>　　Zafgen公司负责人表示，在beloranib目前的临床试验中尚未发现严重的副作用或实验室指标异常，并将于2014年上半年尽快开展该药的2b期临床试验。<br><br>beloranib：一个无需节食、无需运动的强力减肥药<br><br>今天从网友xgyblog处了解到减肥药beloranib (ZGN-433)，它有三个亮点特别吸人眼球：<br><br><img class="ke_img" src="http://xqimg.imedao.com/1481fc497447f3feadd9a344.jpg!custom.jpg" /><br><br>（1）beloranib是MetAP2抑制剂，更直接地说是烟曲霉素（fumagillin）类似物，原本作为抗血管生成药物治疗肿瘤，用于减肥属于first-in-class。beloranib减肥的药理机制尚未完全明确，据称抑制MetAP2会导致脂肪合成减少，同时氧化分解增加。Zafgen Inc.将一个抗癌药用于减肥并推上临床II期，真是勇气可嘉。<br><br>（2）6月22日，Zafgen公司公布了II期临床研究结果：患者（平均年龄为40.3，平均体重为101.2 kg，平均BMI为37.9 kg/m2）随机分为0.6 mg (n = 37)、1.2 mg (n = 37)、2.4 mg (n = 36)、安慰剂(n = 38)四组，治疗12周后平均体重变化分别为-3.8 kg、-6.1 kg、-9.9 kg、+1.8 kg。临床试验中常见不良反应为恶心、呕吐、失眠，未发现严重不良反应或死亡。<br><br>（3）个人以为beloranib最大的亮点还是在于“patients were allowed to eat normally and were not counselled to exercise”，不用改变饮食，不用增加运动，这不是所有减肥者的梦想么？<br><br>Beloranib在有效性上可能优于Belviq和利拉鲁肽，另外它还能降低甘油三酯和LDL-C。但减肥药最重要的还是安全性，悬着的那把刀随时可以将beloranib切碎，如果患者知道它原来是癌症化疗药会怎么想？这就是信心比黄金更重要么？<br><br>利拉鲁肽的临床数据：<br><br>3731例患者按2:1随机分成3mg利拉鲁肽组和安慰剂组，辅以节食和运动。治疗56周后，利拉鲁肽组平均体重下降8%，64%的患者体重下降超过5%，33%的患者体重下降超过10%；安慰剂组平均体重下降2.6%，27%的患者体重下降超过5%，10%的患者体重下降超过10%。<br><br>Belviq的临床数据：<br><br>两项共涉及7190例肥胖病人的临床研究显示，Belviq治疗52周后，平均体重下降5.8%，47.1%的患者体重下降超过5%，22.4%的患者体重下降超过10%；安慰剂组平均体重下降2.5%，22.6%的患者体重下降超过5%，8.7%的患者体重下降超过10%。<br><br><a href="http://xueqiu.com/n/招财资本"  target="_blank">@招财资本</a> <a href="http://xueqiu.com/n/chaseslime"  target="_blank">@chaseslime</a> <a href="http://xueqiu.com/n/Pnmk"  target="_blank">@Pnmk</a> <a href="http://xueqiu.com/n/金刚小黄人"  target="_blank">@金刚小黄人</a></div></div><p style="display:none" class="donators-tip">已有<em class="donators-count">0</em>人赞助了这篇帖子<em data-count="0" class="snow-coin">0</em>雪球币:</p><ul id="donator-list"></ul><div class="meta"><a href="/2489249469/31169985" class="createTime">08-29 11:19</a>来自<span>雪球</span><span class="ops"><a href="#" class="statusRepost">转发(4)</a><!--a.share(href="#")--><!--  |分享--><a href="#" class="statusFav">收藏</a><a href="#" class="donate">赞助<span style="display:none;" class="number">(<em data-count="0}" class="snow-coin">0</em>)</span></a><a href="#" class="statusComment last">评论(10)</a></span></div></div><div class="commentContainer head-list"></div><script>SNB.data.status = {"id":31169985,"user_id":2489249469,"title":"新型减肥药beloranib临床试验结果喜人","created_at":1409282306000,"retweet_count":4,"reply_count":10,"fav_count":0,"truncated":false,"commentId":0,"retweet_status_id":0,"description":"美国Zafgen公司公布了一项作用机制不同于以往的新型减肥药的临床试验结果，结果显示该药能使肥胖患者减重24磅或减轻原先体重的11%。 这种名为beloranib的注射剂型减肥新药由Zafgen公司生产，该药在降低血HDL-C及血压水平方面的有效性和安全性在二期临床试验中得到了充分肯定。 纵观减肥市场，各种...","type":"3","source_link":null,"edited_at":null,"pic":"http://xqimg.imedao.com/1481fc497447f3feadd9a344.jpg!thumb.jpg","user":{"status":1,"common_count":0,"remark":null,"screen_name":"我是_一级棒","verified":false,"verified_type":0,"profile":"/smarttraders168","verified_description":null,"followers_count":2677,"status_count":631,"friends_count":34,"last_status_id":31969497,"donate_count":1,"blocking":false,"following":false,"follow_me":false,"recommend":null,"city":"城市/地区","gender":"m","province":"广东","st_color":"0","allow_all_stock":false,"step":"three","blog_description":null,"intro":null,"stock_status_count":null,"stocks_count":null,"domain":"smarttraders168","name":null,"location":null,"id":2489249469,"type":"1","url":null,"description":"小赌怡情，大赌致富。宇宙职业独立投资人。","stats":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"photo_domain":"http://xavatar.imedao.com/","profile_image_url":"community/20149/1412354828279-1412354828652.jpg!50x50.png"},"retweeted_status":null,"target":"/2489249469/31169985","fragment":null,"blocked":null,"blocking":false,"topic_pic":null,"topic_symbol":null,"topic_title":null,"topic_desc":null,"donate_count":0,"donate_snowcoin":0,"view_count":0,"mark":0,"favorited":false,"favorited_created_at":null,"canEdit":true,"timeBefore":"08-29 11:18","expend":true,"firstImg":"http://xqimg.imedao.com/1481fc497447f3feadd9a344.jpg!thumb.jpg","topic_pic_thumbnail_small":null,"topic_pic_thumbnail":null,"topic_pic_headOrPad":null,"text":"美国Zafgen公司公布了一项作用机制不同于以往的新型减肥药的临床试验结果，结果显示该药能使肥胖患者减重24磅或减轻原先体重的11%。<br><br>　　这种名为beloranib的注射剂型减肥新药由Zafgen公司生产，该药在降低血HDL-C及血压水平方面的有效性和安全性在二期临床试验中得到了充分肯定。<br><br>　　纵观减肥市场，各种减肥药物层出不穷，已有相当一部分减肥药物因存在安全隐患而被撤市。减肥药安全性方面的担忧主要与其作用机制有关——大多数减肥药通过向大脑传递饱食感的信号而抑制食欲。<br><br>　　美国FDA于2012年年中批准了减肥药Qsymia(一种苯丁胺和托吡酯的混合缓释制剂)和Belviq(氯卡色林)的上市，上述两种药物的作用机制主要与大脑信号转导有关，具体通路尚不清楚。然而均存在一定程度的副作用，包括引起抑郁焦虑情绪、心脏损害，甚至可致畸。<br><br>　　beloranib的作用机制与传统减肥药有所不同，它主要通过抑制脂酸产生和利用过程中的关键酶甲硫氨酰氨肽酶-2(MetAP2)的活性，从而使机体脂质的产生减少，代谢增加。<br><br>　　147名肥胖患者参与了此次临床试验，结果显示，在经过12周的治疗后，beloranib组(用药达最大剂量)与安慰剂组的受试者分别减重24磅和0.9磅。<br><br>　　Qsymia的两组独立后期试验(平均疗程为56周)结果显示患者分别减重30磅和37磅，Belviq的一项临床试验(疗程为52周)结果显示患者平均减重17磅。<br><br>　　Beloranib最常见的副作用包括恶心，腹泻，头痛，注射局部淤血及失眠。<br><br>　　Zafgen公司负责人表示，在beloranib目前的临床试验中尚未发现严重的副作用或实验室指标异常，并将于2014年上半年尽快开展该药的2b期临床试验。<br><br>beloranib：一个无需节食、无需运动的强力减肥药<br><br>今天从网友xgyblog处了解到减肥药beloranib (ZGN-433)，它有三个亮点特别吸人眼球：<br><br><img class=\"ke_img\" src=\"http://xqimg.imedao.com/1481fc497447f3feadd9a344.jpg!custom.jpg\" /><br><br>（1）beloranib是MetAP2抑制剂，更直接地说是烟曲霉素（fumagillin）类似物，原本作为抗血管生成药物治疗肿瘤，用于减肥属于first-in-class。beloranib减肥的药理机制尚未完全明确，据称抑制MetAP2会导致脂肪合成减少，同时氧化分解增加。Zafgen Inc.将一个抗癌药用于减肥并推上临床II期，真是勇气可嘉。<br><br>（2）6月22日，Zafgen公司公布了II期临床研究结果：患者（平均年龄为40.3，平均体重为101.2 kg，平均BMI为37.9 kg/m2）随机分为0.6 mg (n = 37)、1.2 mg (n = 37)、2.4 mg (n = 36)、安慰剂(n = 38)四组，治疗12周后平均体重变化分别为-3.8 kg、-6.1 kg、-9.9 kg、+1.8 kg。临床试验中常见不良反应为恶心、呕吐、失眠，未发现严重不良反应或死亡。<br><br>（3）个人以为beloranib最大的亮点还是在于“patients were allowed to eat normally and were not counselled to exercise”，不用改变饮食，不用增加运动，这不是所有减肥者的梦想么？<br><br>Beloranib在有效性上可能优于Belviq和利拉鲁肽，另外它还能降低甘油三酯和LDL-C。但减肥药最重要的还是安全性，悬着的那把刀随时可以将beloranib切碎，如果患者知道它原来是癌症化疗药会怎么想？这就是信心比黄金更重要么？<br><br>利拉鲁肽的临床数据：<br><br>3731例患者按2:1随机分成3mg利拉鲁肽组和安慰剂组，辅以节食和运动。治疗56周后，利拉鲁肽组平均体重下降8%，64%的患者体重下降超过5%，33%的患者体重下降超过10%；安慰剂组平均体重下降2.6%，27%的患者体重下降超过5%，10%的患者体重下降超过10%。<br><br>Belviq的临床数据：<br><br>两项共涉及7190例肥胖病人的临床研究显示，Belviq治疗52周后，平均体重下降5.8%，47.1%的患者体重下降超过5%，22.4%的患者体重下降超过10%；安慰剂组平均体重下降2.5%，22.6%的患者体重下降超过5%，8.7%的患者体重下降超过10%。<br><br><a href=\"http://xueqiu.com/n/招财资本\"  target=\"_blank\">@招财资本</a> <a href=\"http://xueqiu.com/n/chaseslime\"  target=\"_blank\">@chaseslime</a> <a href=\"http://xueqiu.com/n/Pnmk\"  target=\"_blank\">@Pnmk</a> <a href=\"http://xueqiu.com/n/金刚小黄人\"  target=\"_blank\">@金刚小黄人</a>","source":"雪球","time":"08-29 11:19","parsedContent":"美国Zafgen公司公布了一项作用机制不同于以往的新型减肥药的临床试验结果，结果显示该药能使肥胖患者减重24磅或减轻原先体重的11%。<br><br>　　这种名为beloranib的注射剂型减肥新药由Zafgen公司生产，该药在降低血HDL-C及血压水平方面的有效性和安全性在二期临床试验中得到了充分肯定。<br><br>　　纵观减肥市场，各种减肥药物层出不穷，已有相当一部分减肥药物因存在安全隐患而被撤市。减肥药安全性方面的担忧主要与其作用机制有关——大多数减肥药通过向大脑传递饱食感的信号而抑制食欲。<br><br>　　美国FDA于2012年年中批准了减肥药Qsymia(一种苯丁胺和托吡酯的混合缓释制剂)和Belviq(氯卡色林)的上市，上述两种药物的作用机制主要与大脑信号转导有关，具体通路尚不清楚。然而均存在一定程度的副作用，包括引起抑郁焦虑情绪、心脏损害，甚至可致畸。<br><br>　　beloranib的作用机制与传统减肥药有所不同，它主要通过抑制脂酸产生和利用过程中的关键酶甲硫氨酰氨肽酶-2(MetAP2)的活性，从而使机体脂质的产生减少，代谢增加。<br><br>　　147名肥胖患者参与了此次临床试验，结果显示，在经过12周的治疗后，beloranib组(用药达最大剂量)与安慰剂组的受试者分别减重24磅和0.9磅。<br><br>　　Qsymia的两组独立后期试验(平均疗程为56周)结果显示患者分别减重30磅和37磅，Belviq的一项临床试验(疗程为52周)结果显示患者平均减重17磅。<br><br>　　Beloranib最常见的副作用包括恶心，腹泻，头痛，注射局部淤血及失眠。<br><br>　　Zafgen公司负责人表示，在beloranib目前的临床试验中尚未发现严重的副作用或实验室指标异常，并将于2014年上半年尽快开展该药的2b期临床试验。<br><br>beloranib：一个无需节食、无需运动的强力减肥药<br><br>今天从网友xgyblog处了解到减肥药beloranib (ZGN-433)，它有三个亮点特别吸人眼球：<br><br><img class=\"ke_img\" src=\"http://xqimg.imedao.com/1481fc497447f3feadd9a344.jpg!custom.jpg\" /><br><br>（1）beloranib是MetAP2抑制剂，更直接地说是烟曲霉素（fumagillin）类似物，原本作为抗血管生成药物治疗肿瘤，用于减肥属于first-in-class。beloranib减肥的药理机制尚未完全明确，据称抑制MetAP2会导致脂肪合成减少，同时氧化分解增加。Zafgen Inc.将一个抗癌药用于减肥并推上临床II期，真是勇气可嘉。<br><br>（2）6月22日，Zafgen公司公布了II期临床研究结果：患者（平均年龄为40.3，平均体重为101.2 kg，平均BMI为37.9 kg/m2）随机分为0.6 mg (n = 37)、1.2 mg (n = 37)、2.4 mg (n = 36)、安慰剂(n = 38)四组，治疗12周后平均体重变化分别为-3.8 kg、-6.1 kg、-9.9 kg、+1.8 kg。临床试验中常见不良反应为恶心、呕吐、失眠，未发现严重不良反应或死亡。<br><br>（3）个人以为beloranib最大的亮点还是在于“patients were allowed to eat normally and were not counselled to exercise”，不用改变饮食，不用增加运动，这不是所有减肥者的梦想么？<br><br>Beloranib在有效性上可能优于Belviq和利拉鲁肽，另外它还能降低甘油三酯和LDL-C。但减肥药最重要的还是安全性，悬着的那把刀随时可以将beloranib切碎，如果患者知道它原来是癌症化疗药会怎么想？这就是信心比黄金更重要么？<br><br>利拉鲁肽的临床数据：<br><br>3731例患者按2:1随机分成3mg利拉鲁肽组和安慰剂组，辅以节食和运动。治疗56周后，利拉鲁肽组平均体重下降8%，64%的患者体重下降超过5%，33%的患者体重下降超过10%；安慰剂组平均体重下降2.6%，27%的患者体重下降超过5%，10%的患者体重下降超过10%。<br><br>Belviq的临床数据：<br><br>两项共涉及7190例肥胖病人的临床研究显示，Belviq治疗52周后，平均体重下降5.8%，47.1%的患者体重下降超过5%，22.4%的患者体重下降超过10%；安慰剂组平均体重下降2.5%，22.6%的患者体重下降超过5%，8.7%的患者体重下降超过10%。<br><br><a href=\"http://xueqiu.com/n/招财资本\"  target=\"_blank\">@招财资本</a> <a href=\"http://xueqiu.com/n/chaseslime\"  target=\"_blank\">@chaseslime</a> <a href=\"http://xueqiu.com/n/Pnmk\"  target=\"_blank\">@Pnmk</a> <a href=\"http://xueqiu.com/n/金刚小黄人\"  target=\"_blank\">@金刚小黄人</a>","pdfRemovedContent":"美国Zafgen公司公布了一项作用机制不同于以往的新型减肥药的临床试验结果，结果显示该药能使肥胖患者减重24磅或减轻原先体重的11%。<br><br>　　这种名为beloranib的注射剂型减肥新药由Zafgen公司生产，该药在降低血HDL-C及血压水平方面的有效性和安全性在二期临床试验中得到了充分肯定。<br><br>　　纵观减肥市场，各种减肥药物层出不穷，已有相当一部分减肥药物因存在安全隐患而被撤市。减肥药安全性方面的担忧主要与其作用机制有关——大多数减肥药通过向大脑传递饱食感的信号而抑制食欲。<br><br>　　美国FDA于2012年年中批准了减肥药Qsymia(一种苯丁胺和托吡酯的混合缓释制剂)和Belviq(氯卡色林)的上市，上述两种药物的作用机制主要与大脑信号转导有关，具体通路尚不清楚。然而均存在一定程度的副作用，包括引起抑郁焦虑情绪、心脏损害，甚至可致畸。<br><br>　　beloranib的作用机制与传统减肥药有所不同，它主要通过抑制脂酸产生和利用过程中的关键酶甲硫氨酰氨肽酶-2(MetAP2)的活性，从而使机体脂质的产生减少，代谢增加。<br><br>　　147名肥胖患者参与了此次临床试验，结果显示，在经过12周的治疗后，beloranib组(用药达最大剂量)与安慰剂组的受试者分别减重24磅和0.9磅。<br><br>　　Qsymia的两组独立后期试验(平均疗程为56周)结果显示患者分别减重30磅和37磅，Belviq的一项临床试验(疗程为52周)结果显示患者平均减重17磅。<br><br>　　Beloranib最常见的副作用包括恶心，腹泻，头痛，注射局部淤血及失眠。<br><br>　　Zafgen公司负责人表示，在beloranib目前的临床试验中尚未发现严重的副作用或实验室指标异常，并将于2014年上半年尽快开展该药的2b期临床试验。<br><br>beloranib：一个无需节食、无需运动的强力减肥药<br><br>今天从网友xgyblog处了解到减肥药beloranib (ZGN-433)，它有三个亮点特别吸人眼球：<br><br>（1）beloranib是MetAP2抑制剂，更直接地说是烟曲霉素（fumagillin）类似物，原本作为抗血管生成药物治疗肿瘤，用于减肥属于first-in-class。beloranib减肥的药理机制尚未完全明确，据称抑制MetAP2会导致脂肪合成减少，同时氧化分解增加。Zafgen Inc.将一个抗癌药用于减肥并推上临床II期，真是勇气可嘉。<br><br>（2）6月22日，Zafgen公司公布了II期临床研究结果：患者（平均年龄为40.3，平均体重为101.2 kg，平均BMI为37.9 kg/m2）随机分为0.6 mg (n = 37)、1.2 mg (n = 37)、2.4 mg (n = 36)、安慰剂(n = 38)四组，治疗12周后平均体重变化分别为-3.8 kg、-6.1 kg、-9.9 kg、+1.8 kg。临床试验中常见不良反应为恶心、呕吐、失眠，未发现严重不良反应或死亡。<br><br>（3）个人以为beloranib最大的亮点还是在于“patients were allowed to eat normally and were not counselled to exercise”，不用改变饮食，不用增加运动，这不是所有减肥者的梦想么？<br><br>Beloranib在有效性上可能优于Belviq和利拉鲁肽，另外它还能降低甘油三酯和LDL-C。但减肥药最重要的还是安全性，悬着的那把刀随时可以将beloranib切碎，如果患者知道它原来是癌症化疗药会怎么想？这就是信心比黄金更重要么？<br><br>利拉鲁肽的临床数据：<br><br>3731例患者按2:1随机分成3mg利拉鲁肽组和安慰剂组，辅以节食和运动。治疗56周后，利拉鲁肽组平均体重下降8%，64%的患者体重下降超过5%，33%的患者体重下降超过10%；安慰剂组平均体重下降2.6%，27%的患者体重下降超过5%，10%的患者体重下降超过10%。<br><br>Belviq的临床数据：<br><br>两项共涉及7190例肥胖病人的临床研究显示，Belviq治疗52周后，平均体重下降5.8%，47.1%的患者体重下降超过5%，22.4%的患者体重下降超过10%；安慰剂组平均体重下降2.5%，22.6%的患者体重下降超过5%，8.7%的患者体重下降超过10%。<br><br><a href=\"http://xueqiu.com/n/招财资本\"  target=\"_blank\">@招财资本</a> <a href=\"http://xueqiu.com/n/chaseslime\"  target=\"_blank\">@chaseslime</a> <a href=\"http://xueqiu.com/n/Pnmk\"  target=\"_blank\">@Pnmk</a> <a href=\"http://xueqiu.com/n/金刚小黄人\"  target=\"_blank\">@金刚小黄人</a>"};
SNB.data.currentUserId = 0;
var status_user = SNB.data.status.user,
  retweeted_status = SNB.data.status.retweeted_status;
SNB.data.status_user_id = status_user.id;
SNB.data.retweeted_status_user_id = retweeted_status && retweeted_status.user.id;
SNB.data.comments = {"maxPage":1,"count":10,"page":1,"comments":[{"id":28586485,"user_id":7235830181,"created_at":1411962998000,"in_reply_to_comment_id":28570883,"truncated":false,"root_in_reply_to_status_id":31169985,"retweet_status_id":0,"statusId":0,"edited_at":null,"blocked":null,"blocking":false,"user":{"status":0,"common_count":0,"remark":null,"intro":null,"stock_status_count":null,"follow_me":false,"allow_all_stock":false,"stocks_count":null,"verified_type":0,"province":null,"verified":false,"verified_description":null,"recommend":null,"screen_name":"jefferycai","profile":"/7235830181","followers_count":0,"status_count":0,"friends_count":23,"last_status_id":0,"donate_count":0,"blocking":false,"following":false,"city":null,"gender":null,"st_color":"0","step":"null","blog_description":null,"domain":null,"name":null,"location":null,"id":7235830181,"type":"1","url":null,"description":null,"stats":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"profile_image_url":"community/default/avatar.png,community/default/avatar.png!180x180.png,community/default/avatar.png!50x50.png,community/default/avatar.png!30x30.png","photo_domain":"http://xavatar.imedao.com/"},"reply_remark":null,"reply_verified":false,"reply_verified_type":0,"reply_verified_description":null,"reply_comment":null,"reply_screenName":"我是_一级棒","donate_count":0,"donate_snowcoin":0,"truncated_screen_name":null,"censored":null,"spamType":null,"modifiedSpamType":null,"liked":null,"timeBefore":"09-29 11:56","canEdit":true,"description":"哈哈，bio就是这么跌宕起伏的，DNDN不用悲观的","like_count":0,"text":"哈哈，bio就是这么跌宕起伏的，DNDN不用悲观的","source":"雪球"},{"id":28570883,"user_id":2489249469,"created_at":1411884856000,"in_reply_to_comment_id":28570867,"truncated":false,"root_in_reply_to_status_id":31169985,"retweet_status_id":0,"statusId":0,"edited_at":null,"blocked":null,"blocking":false,"user":{"status":1,"common_count":0,"remark":null,"intro":null,"stock_status_count":null,"follow_me":false,"allow_all_stock":false,"stocks_count":null,"verified_type":0,"province":"广东","verified":false,"verified_description":null,"recommend":null,"screen_name":"我是_一级棒","profile":"/smarttraders168","followers_count":2677,"status_count":631,"friends_count":34,"last_status_id":31969497,"donate_count":1,"blocking":false,"following":false,"city":"城市/地区","gender":"m","st_color":"0","step":"three","blog_description":null,"domain":"smarttraders168","name":null,"location":null,"id":2489249469,"type":"1","url":null,"description":"小赌怡情，大赌致富。宇宙职业独立投资人。","stats":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"profile_image_url":"community/20149/1412354828279-1412354828652.jpg,community/20149/1412354828279-1412354828652.jpg!180x180.png,community/20149/1412354828279-1412354828652.jpg!50x50.png,community/20149/1412354828279-1412354828652.jpg!30x30.png","photo_domain":"http://xavatar.imedao.com/"},"reply_remark":null,"reply_verified":false,"reply_verified_type":0,"reply_verified_description":null,"reply_comment":null,"reply_screenName":"jefferycai","donate_count":0,"donate_snowcoin":0,"truncated_screen_name":null,"censored":null,"spamType":null,"modifiedSpamType":null,"liked":null,"timeBefore":"09-28 14:14","canEdit":true,"description":"不要揪着已经过去的股票嘛，当年DNDN不是也很牛，但都尘归尘土归土了。往前看。<img src=\"http://js.xueqiu.com/images/face/21lol.png\" title=\"[大笑]\" alt=\"[大笑]\"  height=\"24\" />","like_count":0,"text":"不要揪着已经过去的股票嘛，当年DNDN不是也很牛，但都尘归尘土归土了。往前看。<img src=\"http://js.xueqiu.com/images/face/21lol.png\" title=\"[大笑]\" alt=\"[大笑]\"   height=\"24\" />","source":"雪球"},{"id":28570867,"user_id":7235830181,"created_at":1411884769000,"in_reply_to_comment_id":0,"truncated":false,"root_in_reply_to_status_id":31170250,"retweet_status_id":31169985,"statusId":0,"edited_at":null,"blocked":null,"blocking":false,"user":{"status":0,"common_count":0,"remark":null,"intro":null,"stock_status_count":null,"follow_me":false,"allow_all_stock":false,"stocks_count":null,"verified_type":0,"province":null,"verified":false,"verified_description":null,"recommend":null,"screen_name":"jefferycai","profile":"/7235830181","followers_count":0,"status_count":0,"friends_count":23,"last_status_id":0,"donate_count":0,"blocking":false,"following":false,"city":null,"gender":null,"st_color":"0","step":"null","blog_description":null,"domain":null,"name":null,"location":null,"id":7235830181,"type":"1","url":null,"description":null,"stats":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"profile_image_url":"community/default/avatar.png,community/default/avatar.png!180x180.png,community/default/avatar.png!50x50.png,community/default/avatar.png!30x30.png","photo_domain":"http://xavatar.imedao.com/"},"reply_remark":null,"reply_verified":false,"reply_verified_type":0,"reply_verified_description":null,"reply_comment":null,"reply_screenName":"Pnmk","donate_count":0,"donate_snowcoin":0,"truncated_screen_name":null,"censored":null,"spamType":null,"modifiedSpamType":null,"liked":null,"timeBefore":"09-28 14:12","canEdit":true,"description":"VRML，有人了解这支股当年创下的奇迹吗？","like_count":0,"text":"VRML，有人了解这支股当年创下的奇迹吗？","source":"雪球"},{"id":27958928,"user_id":2489249469,"created_at":1409330616000,"in_reply_to_comment_id":27958904,"truncated":false,"root_in_reply_to_status_id":31169985,"retweet_status_id":0,"statusId":0,"edited_at":null,"blocked":null,"blocking":false,"user":{"status":1,"common_count":0,"remark":null,"intro":null,"stock_status_count":null,"follow_me":false,"allow_all_stock":false,"stocks_count":null,"verified_type":0,"province":"广东","verified":false,"verified_description":null,"recommend":null,"screen_name":"我是_一级棒","profile":"/smarttraders168","followers_count":2677,"status_count":631,"friends_count":34,"last_status_id":31969497,"donate_count":1,"blocking":false,"following":false,"city":"城市/地区","gender":"m","st_color":"0","step":"three","blog_description":null,"domain":"smarttraders168","name":null,"location":null,"id":2489249469,"type":"1","url":null,"description":"小赌怡情，大赌致富。宇宙职业独立投资人。","stats":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"profile_image_url":"community/20149/1412354828279-1412354828652.jpg,community/20149/1412354828279-1412354828652.jpg!180x180.png,community/20149/1412354828279-1412354828652.jpg!50x50.png,community/20149/1412354828279-1412354828652.jpg!30x30.png","photo_domain":"http://xavatar.imedao.com/"},"reply_remark":null,"reply_verified":false,"reply_verified_type":0,"reply_verified_description":null,"reply_comment":null,"reply_screenName":"割资本主义羊毛","donate_count":0,"donate_snowcoin":0,"truncated_screen_name":null,"censored":null,"spamType":null,"modifiedSpamType":null,"liked":null,"timeBefore":"08-30 00:43","canEdit":true,"description":"一般小新股都是几万股量，如果是波段的还可以接受吧，但就要控制好仓位，不能当正股那样，不然跌起来跑不掉。","like_count":0,"text":"一般小新股都是几万股量，如果是波段的还可以接受吧，但就要控制好仓位，不能当正股那样，不然跌起来跑不掉。","source":"雪球"},{"id":27958904,"user_id":6448227777,"created_at":1409330436000,"in_reply_to_comment_id":0,"truncated":false,"root_in_reply_to_status_id":31169985,"retweet_status_id":0,"statusId":0,"edited_at":null,"blocked":null,"blocking":false,"user":{"status":0,"common_count":0,"remark":null,"intro":null,"stock_status_count":null,"follow_me":false,"allow_all_stock":false,"stocks_count":null,"verified_type":0,"province":"海外","verified":false,"verified_description":null,"recommend":null,"screen_name":"割资本主义羊毛","profile":"/6448227777","followers_count":4533,"status_count":366,"friends_count":74,"last_status_id":31960676,"donate_count":1,"blocking":false,"following":false,"city":"澳大利亚","gender":"m","st_color":"0","step":"null","blog_description":null,"domain":null,"name":null,"location":null,"id":6448227777,"type":"1","url":null,"description":"羊毛股养成实例，每月安全翻倍：","stats":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"profile_image_url":"community/20146/1406094006578-1406094007218.jpeg,community/20146/1406094006578-1406094007218.jpeg!180x180.png,community/20146/1406094006578-1406094007218.jpeg!50x50.png,community/20146/1406094006578-1406094007218.jpeg!30x30.png","photo_domain":"http://xavatar.imedao.com/"},"reply_remark":null,"reply_verified":null,"reply_verified_type":null,"reply_verified_description":null,"reply_comment":null,"reply_screenName":null,"donate_count":0,"donate_snowcoin":0,"truncated_screen_name":null,"censored":null,"spamType":null,"modifiedSpamType":null,"liked":null,"timeBefore":"08-30 00:40","canEdit":true,"description":"交易量有点低","like_count":0,"text":"交易量有点低","source":"雪球"},{"id":27958835,"user_id":2489249469,"created_at":1409330103000,"in_reply_to_comment_id":0,"truncated":false,"root_in_reply_to_status_id":31169985,"retweet_status_id":0,"statusId":31187206,"edited_at":null,"blocked":null,"blocking":false,"user":{"status":1,"common_count":0,"remark":null,"intro":null,"stock_status_count":null,"follow_me":false,"allow_all_stock":false,"stocks_count":null,"verified_type":0,"province":"广东","verified":false,"verified_description":null,"recommend":null,"screen_name":"我是_一级棒","profile":"/smarttraders168","followers_count":2677,"status_count":631,"friends_count":34,"last_status_id":31969497,"donate_count":1,"blocking":false,"following":false,"city":"城市/地区","gender":"m","st_color":"0","step":"three","blog_description":null,"domain":"smarttraders168","name":null,"location":null,"id":2489249469,"type":"1","url":null,"description":"小赌怡情，大赌致富。宇宙职业独立投资人。","stats":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"profile_image_url":"community/20149/1412354828279-1412354828652.jpg,community/20149/1412354828279-1412354828652.jpg!180x180.png,community/20149/1412354828279-1412354828652.jpg!50x50.png,community/20149/1412354828279-1412354828652.jpg!30x30.png","photo_domain":"http://xavatar.imedao.com/"},"reply_remark":null,"reply_verified":null,"reply_verified_type":null,"reply_verified_description":null,"reply_comment":null,"reply_screenName":null,"donate_count":0,"donate_snowcoin":0,"truncated_screen_name":null,"censored":null,"spamType":null,"modifiedSpamType":null,"liked":null,"timeBefore":"08-30 00:35","canEdit":true,"description":"这货的减肥机理与现在一般的不同，可能是新机理治疗法。<img src=\"http://js.xueqiu.com/images/face/44sikao.png\" title=\"[想一下]\" alt=\"[想一下]\"  height=\"24\" />","like_count":0,"text":"这货的减肥机理与现在一般的不同，可能是新机理治疗法。<img src=\"http://js.xueqiu.com/images/face/44sikao.png\" title=\"[想一下]\" alt=\"[想一下]\"   height=\"24\" />","source":"雪球"},{"id":27945514,"user_id":3158525220,"created_at":1409292923000,"in_reply_to_comment_id":0,"truncated":false,"root_in_reply_to_status_id":31169985,"retweet_status_id":0,"statusId":31173613,"edited_at":null,"blocked":null,"blocking":false,"user":{"status":1,"common_count":0,"remark":null,"intro":null,"stock_status_count":null,"follow_me":false,"allow_all_stock":false,"stocks_count":null,"verified_type":0,"province":"海外","verified":false,"verified_description":null,"recommend":null,"screen_name":"招财资本","profile":"/tradingcat","followers_count":9494,"status_count":3760,"friends_count":508,"last_status_id":31964776,"donate_count":2,"blocking":false,"following":false,"city":"加拿大","gender":"m","st_color":"0","step":"three","blog_description":null,"domain":"tradingcat","name":null,"location":null,"id":3158525220,"type":"1","url":null,"description":"加拿大职业独立美股投资人，http://meiguwiki.com","stats":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"profile_image_url":"community/20145/1403761410462-1403761416403.jpeg,community/20145/1403761410462-1403761416403.jpeg!180x180.png,community/20145/1403761410462-1403761416403.jpeg!50x50.png,community/20145/1403761410462-1403761416403.jpeg!30x30.png","photo_domain":"http://xavatar.imedao.com/"},"reply_remark":null,"reply_verified":null,"reply_verified_type":null,"reply_verified_description":null,"reply_comment":null,"reply_screenName":null,"donate_count":0,"donate_snowcoin":0,"truncated_screen_name":null,"censored":null,"spamType":null,"modifiedSpamType":null,"liked":null,"timeBefore":"08-29 14:15","canEdit":true,"description":".","like_count":0,"text":".","source":"雪球"},{"id":27941872,"user_id":2489249469,"created_at":1409283396000,"in_reply_to_comment_id":27941645,"truncated":false,"root_in_reply_to_status_id":31169985,"retweet_status_id":0,"statusId":31170476,"edited_at":null,"blocked":null,"blocking":false,"user":{"status":1,"common_count":0,"remark":null,"intro":null,"stock_status_count":null,"follow_me":false,"allow_all_stock":false,"stocks_count":null,"verified_type":0,"province":"广东","verified":false,"verified_description":null,"recommend":null,"screen_name":"我是_一级棒","profile":"/smarttraders168","followers_count":2677,"status_count":631,"friends_count":34,"last_status_id":31969497,"donate_count":1,"blocking":false,"following":false,"city":"城市/地区","gender":"m","st_color":"0","step":"three","blog_description":null,"domain":"smarttraders168","name":null,"location":null,"id":2489249469,"type":"1","url":null,"description":"小赌怡情，大赌致富。宇宙职业独立投资人。","stats":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"profile_image_url":"community/20149/1412354828279-1412354828652.jpg,community/20149/1412354828279-1412354828652.jpg!180x180.png,community/20149/1412354828279-1412354828652.jpg!50x50.png,community/20149/1412354828279-1412354828652.jpg!30x30.png","photo_domain":"http://xavatar.imedao.com/"},"reply_remark":null,"reply_verified":false,"reply_verified_type":0,"reply_verified_description":null,"reply_comment":null,"reply_screenName":"Pnmk","donate_count":0,"donate_snowcoin":0,"truncated_screen_name":null,"censored":null,"spamType":null,"modifiedSpamType":null,"liked":null,"timeBefore":"08-29 11:36","canEdit":true,"description":"<a href=\"http://xueqiu.com/n/Pnmk\"  target=\"_blank\">@Pnmk</a> 对，DNDN VNDA HGSI应该是09年的事了。","like_count":0,"text":"<a href=\"http://xueqiu.com/n/Pnmk\"  target=\"_blank\">@Pnmk</a> 对，DNDN VNDA HGSI应该是09年的事了。","source":"雪球"},{"id":27941742,"user_id":1124467622,"created_at":1409283128000,"in_reply_to_comment_id":0,"truncated":false,"root_in_reply_to_status_id":31169985,"retweet_status_id":0,"statusId":0,"edited_at":null,"blocked":null,"blocking":false,"user":{"status":1,"common_count":0,"remark":null,"intro":null,"stock_status_count":null,"follow_me":false,"allow_all_stock":false,"stocks_count":null,"verified_type":0,"province":"湖北","verified":false,"verified_description":null,"recommend":null,"screen_name":"sheboigen","profile":"/1124467622","followers_count":190,"status_count":882,"friends_count":161,"last_status_id":31964237,"donate_count":0,"blocking":false,"following":false,"city":"武汉","gender":"m","st_color":"1","step":"three","blog_description":null,"domain":null,"name":null,"location":null,"id":1124467622,"type":"1","url":null,"description":"observation is important","stats":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"profile_image_url":"community/20146/1405100221836-1405100221947.jpeg,community/20146/1405100221836-1405100221947.jpeg!180x180.png,community/20146/1405100221836-1405100221947.jpeg!50x50.png,community/20146/1405100221836-1405100221947.jpeg!30x30.png","photo_domain":"http://xavatar.imedao.com/"},"reply_remark":null,"reply_verified":null,"reply_verified_type":null,"reply_verified_description":null,"reply_comment":null,"reply_screenName":null,"donate_count":0,"donate_snowcoin":0,"truncated_screen_name":null,"censored":null,"spamType":null,"modifiedSpamType":null,"liked":null,"timeBefore":"08-29 11:32","canEdit":true,"description":"减肥药股已经有好几个了吧","like_count":0,"text":"减肥药股已经有好几个了吧","source":"雪球"},{"id":27941645,"user_id":1268928882,"created_at":1409282905000,"in_reply_to_comment_id":0,"truncated":false,"root_in_reply_to_status_id":31169985,"retweet_status_id":0,"statusId":31170250,"edited_at":null,"blocked":null,"blocking":false,"user":{"status":1,"common_count":0,"remark":null,"intro":null,"stock_status_count":null,"follow_me":false,"allow_all_stock":false,"stocks_count":null,"verified_type":0,"province":"海外","verified":false,"verified_description":null,"recommend":null,"screen_name":"Pnmk","profile":"/1268928882","followers_count":2468,"status_count":1220,"friends_count":28,"last_status_id":31961773,"donate_count":0,"blocking":false,"following":false,"city":"城市/地区","gender":"m","st_color":"0","step":"three","blog_description":null,"domain":null,"name":null,"location":null,"id":1268928882,"type":"1","url":null,"description":"Oneil理论的实践者。还在路上","stats":null,"group_ids":null,"name_pinyin":null,"screenname_pinyin":null,"profile_image_url":"community/20145/1403148340933-1403148341301.jpg,community/20145/1403148340933-1403148341301.jpg!180x180.png,community/20145/1403148340933-1403148341301.jpg!50x50.png,community/20145/1403148340933-1403148341301.jpg!30x30.png","photo_domain":"http://xavatar.imedao.com/"},"reply_remark":null,"reply_verified":null,"reply_verified_type":null,"reply_verified_description":null,"reply_comment":null,"reply_screenName":null,"donate_count":0,"donate_snowcoin":0,"truncated_screen_name":null,"censored":null,"spamType":null,"modifiedSpamType":null,"liked":null,"timeBefore":"08-29 11:28","canEdit":true,"description":"对这个市场谨慎。我至今记得有个传奇故事，当年有个dndn,FDA通过的那天，股价暴涨，有个老外option一夜之间涨了50倍,当他把百万的账户给他的老婆看的时候，两个人一起泪奔。我大约是拿时候起，开始关注option.但如今这个公司......","like_count":0,"text":"对这个市场谨慎。我至今记得有个传奇故事，当年有个dndn,FDA通过的那天，股价暴涨，有个老外option一夜之间涨了50倍,当他把百万的账户给他的老婆看的时候，两个人一起泪奔。我大约是拿时候起，开始关注option.但如今这个公司......","source":"雪球"}],"ids":[28586485,28570883,28570867,27958928,27958904,27958835,27945514,27941872,27941742,27941645]};
SNB.data.comments_loaded = true;
SNB.data.goodComments = {"maxPage":1,"count":5,"page":1,"comments":null};
window["missingtime"] = 1412447590786;

seajs.use(['SNB.status.js', 'widget/donate_tooltip.js', 'single.js'], function () {
  var imageElm = $(".status").find(".ke_img");
  
  if (imageElm.length > 0){
    imageElm.each(function () {
      SNB.Image.zoomIn($(this));
    });
  }
  
  var $fv = $('.flexpaper_viewer');
  
  if ($fv.length) {
    var retweet = $('#jade-single .status .retweet').eq(0).length;
    SNB.Util.pdfLink($fv, retweet? SNB.data.status.retweeted_status.target: SNB.data.status.target, retweet? SNB.data.status.retweeted_status.title: SNB.data.status.title);
  }
});</script></div></div></div><div id="footer"><div class="risk">提示：雪球里任何用户或者嘉宾的发言，都有其特定立场，投资决策需要建立在独立思考之上。</div><div class="copyright"><a href="/about/faq" target="_blank">常见问题</a><a href="/about/contact-us" target="_blank">联系方式</a><a href="/about/jobs" target="_blank">加入我们</a><a href="/about" target="_blank">关于雪球</a><a>© 2014 XUEQIU.COM</a><a href="http://www.miibeian.gov.cn/" target="_blank">京ICP证100666号</a><span>京公海网安备 110108006038</span></div></div><script type="text/javascript">var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "//hm.baidu.com/hm.js?1db88642e346389874251b5a1eded6e3";
  var s = document.getElementsByTagName("script")[0]; 
  s.parentNode.insertBefore(hm, s);
})();
</script><!--end baidu tongji--><!--google analytics--><script type="text/javascript">var _gaq = _gaq || [];
 _gaq.push(['_setAccount', 'UA-16079156-4']);
 _gaq.push(['_setDomainName', 'none']);
 _gaq.push(['_trackPageview']);
 
 (function() {
   var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
   ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
   var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
 })();
 
 window.onerror = function(message, file, line) {
   var sFormattedMessage = '[' + file + ' (' + line + ')]' + message;
   _gaq.push(['_trackEvent', 'Exceptions', 'Application', sFormattedMessage, null, true]);
 }</script><!--end google analytics--></body></html>